Johanna Mercier

Johanna Mercier

Director/Board Member at ARCUS BIOSCIENCES, INC.

Net worth: 18 M $ as of 31/05/2026

56 year
Health Technology
Consumer Services
Health Services

Profile

Ms. Johanna Mercier is a Chief Commercial Officer at Gilead Sciences, Inc. and a Member at World 50, Inc. She is on the Board of Directors at Neurocrine Biosciences, Inc., Leonard D Schaeffer Center For Health Policy & Economics and Robert Wood Johnson University Hospital, Inc. Ms. Mercier was previously employed as a President-US Commercial by Bristol Myers Squibb Co. She received her undergraduate degree from the University of Montréal and an MBA from Concordia University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/06/2026 1,24,234 ( 0.01% ) 17 M $ 31/05/2026
27/05/2026 6,853 ( 0.01% ) 1 M $ 31/05/2026

Johanna Mercier active positions

CompaniesPositionStart
GILEAD SCIENCES, INC. Corporate Officer/Principal 01/07/2019
NEUROCRINE BIOSCIENCES, INC. Director/Board Member 15/04/2021
ARCUS BIOSCIENCES, INC. Director/Board Member 29/01/2024
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal -

Former positions of Johanna Mercier

CompaniesPositionEnd
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 01/06/2019
See the detail of Johanna Mercier's experience

Training of Johanna Mercier

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

43

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Services

Technology Services

Health Technology

Consumer Services

  1. Stock Market
  2. Insiders
  3. Johanna Mercier